UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: a phase III randomized controlled trial

Journal of hepatology, 2016-12, Vol.65 (6), p.1112-1119

2016

Volltextzugriff (PDF)

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study

Therapeutic advances in respiratory disease, 2023-01, Vol.17, p.17534666231164534-17534666231164534

2023

Volltextzugriff (PDF)

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

Arteriosclerosis, thrombosis, and vascular biology, 2001-01, Vol.21 (1), p.115-121

2001

Volltextzugriff (PDF)

Lipid-based emulsion drug delivery systems — a comprehensive review

Drug delivery and translational research, 2022-07, Vol.12 (7), p.1616-1639

2022

Volltextzugriff (PDF)

Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3

Nature genetics, 1994-05, Vol.7 (1), p.34-39

1994

Volltextzugriff (PDF)

HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY

Chest, 2023-10, Vol.164 (4), p.A4969-A4970

2023

Volltextzugriff (PDF)

PROMPT INITIATION OF MAINTENANCE THERAPY IN THE UNITED STATES (PRIMUS): AN ANALYSIS OF TRIPLE THERAPY FOLLOWING A DISEASE EXACERBATION AMONG PATIENTS WITH COPD

Chest, 2021-10, Vol.160 (4), p.A1809-A1810

2021

Volltextzugriff (PDF)

PROMPTLY INITIATING TRIPLE THERAPY FOLLOWING SECOND MODERATE EXACERBATION AMONG PATIENTS WITH COPD IN THE UNITED STATES: ANALYSIS OF THE PRIMUS STUDY

Chest, 2022-10, Vol.162 (4), p.A1901-A1902

2022

Volltextzugriff (PDF)

CHARACTERISTICS OF EARLY ADOPTERS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL: A SINGLE-INHALER TRIPLE THERAPY FOR COPD

Chest, 2022-10, Vol.162 (4), p.A1887-A1888

2022

Volltextzugriff (PDF)

Understanding Treatment of Severe Anemia due to CKD: A Descriptive Study in Non-Dialysis Medicare Advantage Prescription Drug Plan Patients: PO0273

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.135-135

2020

Volltextzugriff (PDF)

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study

Journal of managed care & specialty pharmacy, 2022-12, Vol.28 (12), p.1366-1377

2022

Volltextzugriff (PDF)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/ Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS

International journal of chronic obstructive pulmonary disease, 2023-10, Vol.18, p.2245

2023

Volltextzugriff (PDF)

PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation

International journal of chronic obstructive pulmonary disease, 2022-01, Vol.17, p.329-342

2022

Volltextzugriff (PDF)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]

International journal of chronic obstructive pulmonary disease, 2024-08, Vol.19, p.1799-1800

2024

Volltextzugriff (PDF)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

International journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.2245-2256

2023

Volltextzugriff (PDF)

A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro

Journal of lipid research, 1999-10, Vol.40 (10), p.1747-1757

1999

Volltextzugriff (PDF)

Evaluation of the role of UGT1A1 genotype testing in colorectal cancer patients administered irinotecan and the occurence of grade 3 and 4 neutropenia

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.412-412

2012

Volltextzugriff (PDF)

Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir

Patient preference and adherence, 2018-01, Vol.12, p.2631-2638

2018

Volltextzugriff (PDF)

Infectious agents are not necessary for murine atherogenesis

The Journal of experimental medicine, 2000-04, Vol.191 (8), p.1437-1442

2000

Volltextzugriff (PDF)

Isolation of plasma membrane complexes from Xenopus oocytes

The Journal of membrane biology, 1989-02, Vol.107 (2), p.189-201

1989

Volltextzugriff (PDF)

Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization

Journal of managed care pharmacy, 2010-01, Vol.16 (1), p.15-22

2010

Volltextzugriff (PDF)

ApoE−/− Mice Develop Atherosclerosis in the Absence of Complement Component C5

Biochemical and biophysical research communications, 2001-08, Vol.286 (1), p.164-170

2001

Volltextzugriff (PDF)

Isolation of plasma membrane complexes fromXenopus oocytes

The Journal of membrane biology, 1989-02, Vol.107 (2), p.189-201

1989

Volltextzugriff (PDF)

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme

Neurosurgery, 2000-05, Vol.46 (5), p.1123-1130

2000

Volltextzugriff (PDF)

A target for cholesterol absorption inhibitors in the enterocyte brush border membrane

Biochimica et biophysica acta, 2000-07, Vol.1486 (2), p.243-252

2000

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: a phase III randomized controlled trial

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

Lipid-based emulsion drug delivery systems — a comprehensive review

Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3

HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY

PROMPT INITIATION OF MAINTENANCE THERAPY IN THE UNITED STATES (PRIMUS): AN ANALYSIS OF TRIPLE THERAPY FOLLOWING A DISEASE EXACERBATION AMONG PATIENTS WITH COPD

PROMPTLY INITIATING TRIPLE THERAPY FOLLOWING SECOND MODERATE EXACERBATION AMONG PATIENTS WITH COPD IN THE UNITED STATES: ANALYSIS OF THE PRIMUS STUDY

CHARACTERISTICS OF EARLY ADOPTERS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL: A SINGLE-INHALER TRIPLE THERAPY FOR COPD

Understanding Treatment of Severe Anemia due to CKD: A Descriptive Study in Non-Dialysis Medicare Advantage Prescription Drug Plan Patients: PO0273

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/ Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS

PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro

Evaluation of the role of UGT1A1 genotype testing in colorectal cancer patients administered irinotecan and the occurence of grade 3 and 4 neutropenia

Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir

Infectious agents are not necessary for murine atherogenesis

Isolation of plasma membrane complexes from Xenopus oocytes

Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization

ApoE−/− Mice Develop Atherosclerosis in the Absence of Complement Component C5

Isolation of plasma membrane complexes fromXenopus oocytes

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme

A target for cholesterol absorption inhibitors in the enterocyte brush border membrane

Suchergebnisse filtern